StemBioSys, Inc. is a privately held biomedical company in San Antonio, Texas. Our technologies represent the next evolution in cell research and are branded to the research market under the CELLvo™ label.
Principal Investigator(s)
Todd Herron, Ph.D. ; Travis Block, Ph.D.
Funded by
NIH - NIEHS
Collaborating Institutions
Cartox, Inc. ; University of Michigan
CARTOX and StemBioSys will use SBIR funds to develop a reliable, cost-effective high throughput electrophysiology screening assay system for assessing the impact of compounds on human induced pluripotent stem cell derived cardiomyocyte (hiPSC-CM) function. The new technology will address the growing need for a human cardiac system assay to accurately and precisely determine the cardiac safety liability of any drug in development.
StemBioSys, Inc. is a privately held biomedical company in San Antonio, Texas. Our technologies represent the next evolution in cell research and are branded to the research market under the CELLvo™ label.
Principal Investigator(s)
Travis Block, Ph.D.
Funded by
NIH
Our group has recently licensed a technology enabling the identification, isolation, and subsequent
expansion of “youthful” mesenchymal stem cells (MSCs) from elderly individuals. This population is
